Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma

• Published in: NPJ precision oncology Vol. 5; no. 1; p. 6
• Main Authors: Jiang, Tao, Yan, Yan, Zhou, Kun, Su, Chunxia, Ren, Shengxiang, Li, Nan, Hou, Likun, Guo, Xianchao, Zhu, Wei, Zhang, Henghui, Lin, Jie, Zhang, Jun, Zhou, Caicun
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 12.02.2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/67/1612/1350; 631/67/322; Brain cancer; Cancer Research; Gene Therapy; Human Genetics; Internal Medicine; Lung cancer; Lymphatic system; Lymphocytes; Medicine; Medicine & Public Health; Metastasis; Mutation; Oncology; Pathogenesis; Phylogenetics; Thoracic surgery; Tumors
• ISSN: 2397-768X; 2397-768X
• DOI: 10.1038/s41698-021-00151-w

Characterizing the evolutionary trajectory and immune profiling of brain metastasis (BM) may provide insights in the development of novel therapeutic strategies. Here, we performed whole-exome sequencing and multiplex immunofluorescence (MIF) of 40 samples from 12 lung adenocarcinoma (LUAD) patients with BM and compared to their paired primary tumors. We observed significantly higher intertumor heterogeneity between paired primary tumors and BMs, with only a median of 8.3% of genetic mutations identified as shared. Phylogenetic analysis revealed that BM-competent clones genetically diverged from their primary tumors at relatively early stage, suggesting that the parallel progression model is dominant. In cases with synchronous lymph node metastasis (LNM), phylogenetic analysis suggested that BM is a later event than LNM. MIF analysis found that BMs exhibited significantly lower CD8 + T cell infiltration ( P  = 0.048), and elevated CD4 + Foxp3 + T cell infiltration ( P  = 0.036) and PD-1 expression ( P  = 0.047) in comparison to the matched primary tumors, indicating an immunosuppressive microenvironment in BMs. The current study revealed the discrepancy of mutational landscape as well as tumor immune microenvironment between BM and its primary tumor – such findings shall help us better understand the unique biological features of BM and develop innovative strategies accordingly for our patients with LUAD.